<DOC>
	<DOCNO>NCT02597790</DOCNO>
	<brief_summary>The CTSI-PLACE Study study men woman HIV/hepatitis C co-infection HIV . The study look impact hepatitis C virus addition HIV risk cardiovascular disease . Participants undergo non-invasive assessment cardiovascular disease risk measurement endothelial function blood biomarkers baseline 1 year ( 4 week end HCV treatment undergo HCV treatment study follow-up ) .</brief_summary>
	<brief_title>A Prospective , Longitudinal Study Endothelial Function HIV/HCV Coinfected Subjects</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<criteria>Inclusion Criteria 1 . Men woman â‰¥ 18 year 2 . Hepatitis C negative chronic hepatitis C infection 3 . Chronic HIV infection 4 . CD4+ Tcell count &gt; 200 cells/mm3 5 . Plasma HIV1 RNA &lt; 50 copies/mL 6 . On continuous stable ART least 12 week 7 . Ability willingness provide write informed consent . Exclusion Criteria 1 . Known cardiovascular disease 2 . Diabetes require insulin therapy hemoglobin A1c &gt; 8 % 3 . Inability conform requirement PAT test 4 . Decompensated liver disease 5 . Other known cause significant liver disease 6 . Serious illness include acute liverrelated disease malignancy require systemic treatment hospitalization within 12 week prior study entry 7 . Presence active acute AIDSdefining opportunistic infection ( OIs ) within 12 week prior study entry 8 . History major organ transplantation exist functional graft immunosuppressive therapy 9 . History known vascular autoimmune disease 10 . Pregnancy 11 . HCV treatment ( approved investigational agent ) within 24 week prior study entry 12 . Use immunebased therapy systemic corticosteroid within 12 week prior study entry 13 . Advanced renal insufficiency define glomerular filtration rate ( GFR ) &lt; 30 mL/min/1.73 m2 treatment dialysis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>endothelial function</keyword>
	<keyword>cardiovascular risk</keyword>
	<keyword>HIV</keyword>
	<keyword>Hepatitis C</keyword>
	<keyword>metabolic disease</keyword>
	<keyword>inflammation</keyword>
</DOC>